Catalyst Wire Dossier Catalyst Wire Dossier

Carfilzomib

carfilzomib · Amgen
Drug timelines are a Plus or Pro feature.

89 regulatory and trial events tracked for Carfilzomib, covering 2013-12-09 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM) [Phase 3]

See pricing